INSIDER · CIK 1722140
Ceesay Abraham
Chief Executive Officer, Director at Rapport Therapeutics, Inc. (RAPP)
↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$4.0MSold on the market
1Companies
Oct 23, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 202616:30 | Oct 21, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $29.16 | −2,210 | 450,035 | -0% | −$64K | ||
| Oct 8, 202616:07 | Oct 7, 2026from Oct 6, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $31.68 | −4,522 | 452,245 | -1% | −$143K | ||
| Sep 24, 202616:05 | Sep 23, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $39.17 | −2,210 | 456,767 | -0% | −$87K | ||
| Sep 9, 202616:05 | Sep 8, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $45.61 | −8,210 | 458,977 | -2% | −$374K | ||
| Aug 26, 202616:05 | Aug 25, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $49.57 | −18,921 | 467,187 | -4% | −$938K | ||
| Aug 12, 202616:35 | Aug 11, 2026from Aug 10, 2026 | RAPPRapport Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $47.25 | −51,499 | 486,108 | -10% | −$2.4M |